Trademark: 98002517
Word
KYNLUVON
Status
Pending
Status Code
686
Status Date
Tuesday, April 2, 2024
Serial Number
98002517
Mark Type
4000
Filing Date
Thursday, May 18, 2023
Published for Opposition
Tuesday, April 2, 2024

Trademark Owner History
Genzyme Corporation - Owner At Publication

Classifications
5 Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's

Trademark Events
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 23, 2024
Approved For Pub - Principal Register
Feb 23, 2024
Examiner's Amendment Entered
Feb 23, 2024
Notification Of Examiners Amendment E-Mailed
Feb 23, 2024
Examiners Amendment E-Mailed
Feb 23, 2024
Examiners Amendment -Written
Feb 12, 2024
Assigned To Examiner
Nov 7, 2023
Preliminary/Voluntary Amendment - Entered
Nov 6, 2023
Assigned To Lie
Jun 2, 2023
Teas Voluntary Amendment Received
Jun 20, 2023
New Application Office Supplied Data Entered
Jun 8, 2023
Teas Change Of Correspondence Received
Jun 8, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 8, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 22, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24